Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04998669
Title Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Juan P. Alderuccio, MD

follicular lymphoma


Loncastuximab tesirine-lpyl + Rituximab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.